2009 Annual Saturday

Orlando, FL - ASCO 2009 Annual Meeting: J. Neoptolemos discusses Abstract LBA4505 - ESPAC-3(v2) - A multicentre, international, open label, randomised controlled phase III trial of adjuvant 5-fluorouracil/folinic acid (5-FU/FA) versus gemcitabine (GEM) in patients with resected pancreatic ductal adenocarcinoma. during the Oral Presentation at the American Society for Clinical Oncology Annual Meeting here today, Saturday May 30, 2009. Over 25,000 physicians, researchers and healthcare professionals from over 80 countries are attending the meeting which is being held at the Orange County Convention center and features the latest cancer research in the areas of basic and clinical science. Date: Saturday May 30, 2009 Photo by © ASCO/Zach Boyden-Holmes 2009 Technical Questions: todd@toddbuchanan.com; Phone: 612-226-5154.